Signed in
We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
| $20.07% | |
| $10.05% | |
| $0.760.04% | |
| $0.300.01% | |
| $0.190.01% | |
| $0.030.00% | |
| $0.020.00% |
https://www.europeanpharmaceuticalreview.com/news/184106/first-ai-generated-small-molecule-drug-enters-phase-ii-trial/